Luis Requena

Luis Requena

Auto-generated profile, based on publicly available information

Luis Requena

Servicio de Dermatología, Fundación Jiménez Díaz Universidad Autónoma, Madrid, Spain

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2020 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
ICIsabel Colmenero
Isabel Colmenero
CSC. Santonja
C. Santonja
MAM. Alonso‐Riaño
M. Alonso‐Riaño
LNLucero Noguera-Morel
Lucero Noguera-Morel
ÁHÁngela Hernández-Martín
Ángela Hernández-Martín
ATAntonio Torrelo
Antonio Torrelo
Background Chilblains ("COVID toes") are being seen with increasing frequency in children and young adults during the COVID‐19 pandemic. Detailed histopathological descriptions of COVID‐19 chilblains have not been reported, and causality of SARS‐CoV‐2 has not been established yet. Objective To describe histopathological features of Covid‐19 chilblains and explore the presence of SARS‐CoV‐2 in the tissue. Methods We examined skin biopsies from 7 paediatric patients presenting with chilblains during the COVID‐19 pandemic. Immunohistochemistry for SARS‐CoV‐2 was performed in all cases and electron microscopy in one. Results Histopathology showed variable degrees of lymphocytic vasculitis ranging from endothelial swelling and endothelialitis to fibrinoid necrosis and thrombosis. Purpura, superficial and deep perivascular lymphocytic inflammation with perieccrine accentuation, oedema, and mild vacuolar interface damage were also seen. SARS‐CoV‐2 immunohistochemistry was positive in endothelial cells and epithelial cells of eccrine glands. Coronavirus particles were found in the cytoplasm of endothelial cells on electron microscopy. Conclusions Although the clinical and histopathological features were similar to other forms of chilblains, the presence of viral particles in the endothelium and the histological evidence of vascular damage, support a causal relation of the lesions with SARS‐CoV‐2. Endothelial damage induced by the virus could be the key mechanism in the pathogenesis of COVID‐19 chilblains and perhaps also in a group of patients severely affected by COVID‐19 presenting with features of microangiopathic damage.

1 January 2011 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
LRLuis Requena
Luis Requena
CRCelia Requena
Celia Requena
LCLise Christensen
Lise Christensen
UZUte S. Zimmermann
Ute S. Zimmermann
HKHeinz Kutzner
Heinz Kutzner
LCLorenzo Cerroni
Lorenzo Cerroni

1 July 2005 in Archives of Dermatology
Verified
Journal Article
Closed access
PDF file
LRLuis Requena
Luis Requena
HKHeinz Kutzner
Heinz Kutzner
GPGabriele Palmedo
Gabriele Palmedo
MPMarta Pascual
Marta Pascual
JFJesús Fernández-Herrera
Jesús Fernández-Herrera
EYEvaristo Sánchez Yus
Evaristo Sánchez Yus
Research from JAMA Dermatology — Histiocytoid Sweet Syndrome — A Dermal Infiltration of Immature Neutrophilic Granulocytes

1 February 2013 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
LRLuis Requena
Luis Requena
HKHeinz Kutzner
Heinz Kutzner

1 April 2003 in Archives of Dermatology
Verified
Journal Article
Open access
PDF file
LRLuis Requena
Luis Requena
HKHeinz Kutzner
Heinz Kutzner
GPGabriele Palmedo
Gabriele Palmedo
ECEduardo Calonje
Eduardo Calonje
CRCelia Requena
Celia Requena
OSOmar P. Sangueza
Omar P. Sangueza
Research from JAMA Dermatology — Cutaneous Involvement in Multiple Myeloma — A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases

1 April 2009 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
LRLuis Requena
Luis Requena
LELaila El-Shabrawi-Caelen
Laila El-Shabrawi-Caelen
SWSarah N Walsh
Sarah N Walsh
SSSonia Segura
Sonia Segura
MZMirjana Ziemer
Mirjana Ziemer
HKHeinz Kutzner
Heinz Kutzner
Intralymphatic histiocytosis is a rare condition characterized by the presence of dilated lymphatic vessels containing aggregates of mononuclear histiocytes (macrophages) within their lumina. The phenomenon seems to occur almost exclusively within the reticular dermis. Although its pathogenesis remains uncertain, there has been speculation about the possible relationship between intralymphatic histiocytosis and intravascular reactive angioendotheliomatosis. In addition, several examples historically have been associated with rheumatoid arthritis. We describe our experience with 16 cases of intralymphatic histiocytosis. Clinically, the lesions were located predominantly on the upper and lower limbs, and they consisted of asymptomatic and poorly demarcated erythematous plaques and livedo reticularis-like lesions. They were characterized histopathologically by dilated vascular structures involving the reticular dermis. Some of these dilated vessels had empty lumina, whereas others contained variable number of mononuclear histiocytes. An inflammatory response of variable intensity from case to case was also present in the adjacent dermis. The dilated vessels exhibited thin walls with irregular shapes, and a single discontinuous layer of flat endothelial cells lined their lumina. Immunohistochemically, the endothelial cells lining the dilated lumina expressed immunoreactivity for CD31, CD34, podoplanin, D2-40, Lyve-1, and Prox-1, which confirmed their nature as lymphatic endothelial cells. Intralymphatic mononuclear histiocytes expressed CD68 (PGM1), although some cases also had variable immunoexpression for myeloperoxidase, CD31, and podoplanin. In the 4 cases that employed double immunohistochemistry, with podoplanin + CD68 (PGM1) or with Lyve-1 + CD68 (PGM1), each marker highlighted their specific target cells unequivocally; the endothelial cells expressed podoplanin or Lyve-1 immunoreactivity, and intralymphatic histiocytes showed CD68 (PGM1) immunoexpression. Our findings expand on the previously described morphologic and immunohistochemical features of intravascular histiocytosis. We also discuss the possible relationship between intralymphatic histiocytosis and the so-called reactive intravascular angioendotheliomatosis.